Connection

Evangelos Giamarellos-Bourboulis to Treatment Outcome

Back to Details
This is a "connection" page, showing publications Evangelos Giamarellos-Bourboulis has written about Treatment Outcome.
Evangelos Giamarellos-Bourboulis
Connection Strength
0.090
Treatment Outcome
  1. An open label trial of anakinra to prevent respiratory failure in COVID-19. Elife. 2021 03 08; 10.
    View in: PubMed
    Score: 0.033
  2. Infection-free Clinical Response Among Patients With Hidradenitis Suppurativa Who Were Treated With Adalimumab: Results from Two Phase 3 Studies. Wounds. 2017 Nov; 29(11):E98-E102.
    View in: PubMed
    Score: 0.026
  3. Lessons from pathophysiology: Use of individualized combination treatments with immune interventional agents to tackle severe respiratory failure in patients with COVID-19. Eur J Intern Med. 2021 06; 88:52-62.
    View in: PubMed
    Score: 0.008
  4. Beneficial Effects of Intermediate Dosage of Anticoagulation Treatment on the Prognosis of Hospitalized COVID-19 Patients: The ETHRA Study. In Vivo. 2021 Jan-Feb; 35(1):653-661.
    View in: PubMed
    Score: 0.008
  5. Low-dose hydrocortisone prolongs survival in a lethal sepsis model in adrenalectomized rats. J Surg Res. 2018 07; 227:72-80.
    View in: PubMed
    Score: 0.007
  6. Efficacy of intramuscular moxifloxacin in the treatment of experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus. Int J Antimicrob Agents. 2017 Aug; 50(2):186-190.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.